Trupanion (NASDAQ:TRUP) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Trupanion (NASDAQ:TRUP) released its quarterly earnings data on Wednesday. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09, Briefing.com reports. The business had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. Trupanion’s revenue was up 14.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.10) earnings per share. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.

Trupanion Stock Up 3.5 %

Shares of TRUP traded up $1.87 on Wednesday, reaching $55.12. The company’s stock had a trading volume of 771,558 shares, compared to its average volume of 680,043. The stock has a market capitalization of $2.32 billion, a PE ratio of -84.44 and a beta of 1.73. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a twelve month low of $19.14 and a twelve month high of $55.74. The firm has a fifty day moving average of $46.54 and a 200-day moving average of $35.74.

Wall Street Analysts Forecast Growth

TRUP has been the topic of several research reports. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Northland Securities raised their target price on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Bank of America increased their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Stifel Nicolaus upped their price objective on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Finally, William Blair started coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating for the company. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $41.83.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares in the company, valued at $4,647,256.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,764 shares of company stock valued at $405,238. Corporate insiders own 5.50% of the company’s stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.